Citations (2)
Keep up to date with the latest research on this topic with citation updates for this article.
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 37, 2022 - Issue 1
Research Papers
Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations
Alaa Elwana Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt
https://orcid.org/0000-0003-4270-616XView further author information
https://orcid.org/0000-0003-4270-616XView further author information, , , , Mohamed A. Abdelgawadc Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi ArabiaCorrespondence[email protected]
https://orcid.org/0000-0001-9035-5638View further author information
https://orcid.org/0000-0001-9035-5638View further author information, Mohammed M. Ghoneimd Department of Pharmacy Practice, Faculty of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabiahttps://orcid.org/0000-0002-9179-4373View further author information
https://orcid.org/0000-0002-9179-4373View further author information, Mohamed El-Sherbinye Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia;f Department of Anatomy, Faculty of Medicine, Mansoura University, Mansoura, Egypthttps://orcid.org/0000-0002-2689-1409View further author information
https://orcid.org/0000-0002-2689-1409View further author information & Khaled El-Adla Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt;g Chemistry Department, Faculty of Pharmacy, Heliopolis University for Sustainable Development, Cairo, EgyptCorrespondence[email protected] [email protected] [email protected]
https://orcid.org/0000-0002-8922-9770View further author information
https://orcid.org/0000-0002-8922-9770View further author information show all